Type 2 Diabetes

The diagnosis and treatment of depression in the elderly population with type 2 diabetes are essential for managing dementia risks. 

Many adults with type 2 diabetes carry the burden of complicated medication regimens, associated with worse patient outcomes and a higher potential for drug interactions.

A placebo-controlled trial was conducted to determine fetal, neonatal, and maternal outcomes associated with metformin use during pregnancy in women with T2DM.

Findings show Parkinson’s disease risk is reduced in patients with type 2 diabetes mellitus (T2DM) after treatment with exenatide.

Researchers continue to uncover the many ways uncontrolled hyperglycemia can damage the body.

Empagliflozin significantly lowered LVMi, systolic blood pressure, and diastolic blood pressure in patients with CAD and type 2 diabetes.

American Diabetes Association guidelines recommend that combination therapy be started in patients with unachieved glycemic control within three months. 

Researchers say static electromagnetic fields (EMFs) could be a non-invasive and safe way of managing blood glucose.

A recent cohort study offers more insight into whether cat and dog owners and their pets share a risk of acquiring type 2 diabetes. 

Loneliness may increase risk for type 2 diabetes, even in patients who are not socially isolated.